Nausea and Vomiting, Chemotherapy-Induced Clinical Trial
Official title:
An Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Steady-State Warfarin When Co-administered With Repeat Doses of Casopitant [GW679769] in Healthy Adult Subjects.
GW679769 may affect liver enzymes that metabolize warfarin. This study is designed to test the extent of the GW679769 affect on Warfarin levels in humans.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00404378 -
Study Of Healthy Subjects To Assess The Effect Of Ketoconazole And The Way The Body Will React To Casopitant [GW679769]
|
Phase 1 | |
Completed |
NCT00431236 -
A Study of the Drug Casopitant for the Prevention of Nausea Caused By Cisplatin-Based Highly Emetogenic Chemotherapy
|
Phase 3 | |
Completed |
NCT00405080 -
A Study in Healthy Subjects to Assess How Dosing of Rifampin Affects What the Body Does to a Dose of GW679769 (Casopitant).
|
Phase 1 | |
Completed |
NCT00440128 -
The Effects Of GW679769 (Casopitant) On The Pharmacokinetics Of Docetaxel In Subjects With Cancer
|
Phase 1 | |
Completed |
NCT00601172 -
A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting.
|
Phase 3 | |
Completed |
NCT00511823 -
The Pharmacokinetic Interaction Between Oral Casopitant and Oral Dolasetron, Granisetron or Rosiglitazone in Subjects
|
Phase 1 | |
Completed |
NCT00366834 -
Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting
|
Phase 3 | |
Completed |
NCT00437229 -
A Study to Assess the Safety & Interaction Between GW679769, Dexamethasone, & Ondansetron When Taken by Healthy Adults
|
Phase 1 | |
Completed |
NCT00104403 -
Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic Chemotherapy
|
Phase 2 | |
Completed |
NCT01449188 -
To Investigate the Effect of Intravenous Ondansetron on Cardiac Conduction as Compared to Placebo and Moxifloxacin in Healthy Adult Subjects
|
Phase 1 | |
Terminated |
NCT00334646 -
Cyclophosphamide Drug Interaction Study In Cancer Patients
|
Phase 1 | |
Completed |
NCT00460707 -
A Study to Assess the Safety and Interaction Between Casopitant and Ketoconazole When Taken By Healthy Adults
|
Phase 1 |